Literature DB >> 15498521

Venn analysis as part of a bioinformatic approach to prioritize expressed sequence tags from cardiac libraries.

James L McKinney1, Duncan J Murdoch, Jian Wang, John Robinson, Chris Biltcliffe, Hafiz M R Khan, Paul M Walker, Josee Savage, Ilona Skerjanc, Robert A Hegele.   

Abstract

OBJECTIVES: We needed to sort expressed sequence tags (ESTs) from human cardiac expression libraries. DESIGN AND METHODS: We annotated DNA sequence text files of 35,152 cardiac ESTs using our search and annotation tool called Multiblast.pl. We generated lists of the most prevalent ESTs in each library, and using a novel Venn tool, we grouped ESTs that were common to all or exclusive to particular libraries.
RESULTS: Hypothetical protein KIAA0553 was expressed 120 times among 917 ESTs from an adult cardiac library (13.1%) compared only once among 8075 ESTs from fetal cardiac libraries (P < 10(-114)), this was confirmed using Northern analysis. We collated biochemical features of KIAA0553 and determined DNA polymorphism frequencies. We also used the Venn tool to specify genes that were uniquely expressed in hypertrophic cardiomyocytes.
CONCLUSIONS: Annotating ESTs and sorting them using Venn analysis can help specify new candidate disease genes from the current lists of "hypothetical proteins".

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498521     DOI: 10.1016/j.clinbiochem.2004.07.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8.

Authors:  Hiroshi Kaneko; Hiroshi Kitoh; Tohru Matsuura; Akio Masuda; Mikako Ito; Monica Mottes; Frank Rauch; Naoki Ishiguro; Kinji Ohno
Journal:  Hum Genet       Date:  2011-05-19       Impact factor: 4.132

2.  Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes.

Authors:  Mei-Jie Shi; Huan-Ming Xiao; Yu-Bao Xie; Jun-Min Jiang; Peng-Tao Zhao; Gao-Shu Cai; Ying-Xian Li; Sheng Li; Chao-Zhen Zhang; Min-Ling Cao; Qu-Bo Chen; Zhi-Jian Tan; Heng-Jun Gao; Xiao-Ling Chi
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.